ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ONT Oxford Nanopore Technologies Plc

105.00
-1.00 (-0.94%)
12 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Nanopore Technologies Plc LSE:ONT London Ordinary Share GB00BP6S8Z30 ORD GBP0.0001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.94% 105.00 105.70 106.00 108.00 102.90 105.00 1,180,152 16:35:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 169.67M -154.51M -0.1768 -6.01 926.3M
Oxford Nanopore Technologies Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ONT. The last closing price for Oxford Nanopore Technolo... was 106p. Over the last year, Oxford Nanopore Technolo... shares have traded in a share price range of 86.00p to 279.00p.

Oxford Nanopore Technolo... currently has 873,871,414 shares in issue. The market capitalisation of Oxford Nanopore Technolo... is £926.30 million. Oxford Nanopore Technolo... has a price to earnings ratio (PE ratio) of -6.01.

Oxford Nanopore Technolo... Share Discussion Threads

Showing 3151 to 3175 of 3300 messages
Chat Pages: 132  131  130  129  128  127  126  125  124  123  122  121  Older
DateSubjectAuthorDiscuss
01/5/2024
13:21
My feeling is that post Brexit, whether by correlation or causation, UK Plc is like the housing market in 1996. It's a buyer's market. And the tech crown jewels - with double discount of currency depreciation and LSE low value assumptions- are to had for peanuts.
Such things do change, though I fear UK will be out in the cold for a generation, and will lose a large section of its most promising growth companies.

brucie5
01/5/2024
11:42
I've never really put much weight behind this being taken out, but changed my view recently. It certainly adds a bit of jeopardy to selling to take a little profit. One of the big boy LSTools could acquire this for a rounding error and it would add a disproportionate amount of 'value'. They have the customers, routes to market, geographic footprint, synergy etc etc. Pre or post breakeven? Who knows. They won't want a business that's just going to burn through cash and destroy their own EBITDA, but I'd be doing some serious DD if I were a CEO. It's a high value space waiting to be dominated. Given the difficulty of building a start up to here, despite having the benefit of a very well funded (at the time ) cornerstone investor backing all the way, I would still have good confidence in GS pushing a very good deal.
32v31today
01/5/2024
09:53
Maybe start with the premise that this will be bought out in due course; it's just too enormous not to.
Add the expiry of LAT shares in June.
Whack in the 3.5% subscription by Biomerieux at 2.38 last October.
Sprinkle over with heavy director buys in the region of 1.30, or thereabouts; not to mention some recent light seasoning by a NED as reported this morning.
Heat up with the strategic ambiguity of the 15m reported last night.

It may go lower; it may not.

brucie5
01/5/2024
09:27
Should get a holding statement one way or other?looking to buy
tsmith2
01/5/2024
07:31
Small fry 23k, but every little helps.
brucie5
01/5/2024
07:07
More director buying... follow the money buy
seball
01/5/2024
05:49
Given share price weakness would think it was a sellmay have cleared seller - let's see today
tsmith2
30/4/2024
23:25
Looking at prices over the past few trading days, this is likely a late reported trade from Friday and could therefore equally be seen a buy.
bamboo2
30/4/2024
20:28
Just seen it on LSE, thanks. That's huge. 15M sell at 97p.
brucie5
30/4/2024
19:49
Volume 15m. Could seller be finished?
bamboo2
30/4/2024
16:46
And there go. Sellers seem unwilling to let this go.
brucie5
30/4/2024
11:13
Added. Now watch it slip below £1 again.
;)

brucie5
30/4/2024
10:55
Trading update July
tsmith2
30/4/2024
09:16
Well way I see it, it's started to test likely new support at £.
brucie5
30/4/2024
08:53
buying in if we get reversal on strength here
tsmith2
30/4/2024
06:39
Sounds like more waiting on the next ONT results for confirmation of some sort of stabilisation/start of a demand recovery I suppose for me. The challenge is that the market seems to sometimes appreciate before the results (e.g. OXB) and buying in after a spike changes the risk/reward a bit - the joys of investing in recovery plays :)
takeiteasy
29/4/2024
21:39
One take I had from the recent pacb update was how terrible the end market is / has been. I think it hit them more than others. LSTools seem to have reported a better than expected tough period and looking at things picking up further in H2. This isn't based on a particularly deep dive, but nervousness from pacb will hit ONT. Bottom line for me, hopefully end market is picking up from here. I think Bruce nailed calling these prices a while back. My take is that, long term, this is massively mispriced by the market, and so an opportunity (unless you're dipping in and out every 5 minutes, in which case, who knows) . I'd expect to see the price improve very materially during 2024 (so expect it to go down ;) )My view on current price decline is potentially influenced big holders selling down and end market has been really difficult recently. Both of which have hopefully turned/ turning, both of which are hopefully good for share price. That said I've not done any sums on that.Reasons to buy not sell in my book.
32v31today
29/4/2024
18:52
Yes.
;)

brucie5
29/4/2024
18:24
PACB on Nasdaq on a healthy rise up for once - is this stock specific or is there a reconsideration for this sector underway at all
takeiteasy
26/4/2024
16:59
You could see 1.15 without any change in the chart direction. This is just profoundly oversold, afaic. Don't forget BioMerieux agreed to buy 3.5% at 2.38 last October; and very substantial, recent dir buys at £1 below that.
I see a rare historic opportunity at these levels, but obviously there are risks, so each to their own.
Of three analogous situations I follow: OXB starting to recover - ahead of results on Monday; CWR may also have based out.
As to the 'double bottom' here - yes, very possible, though no telling there might not be a third. Depends if there is another large seller still to come.
Absolutely NAI.

brucie5
26/4/2024
16:12
I'm wanting to see a mover up through £1.05 on good volume before dipping toe
tsmith2
26/4/2024
16:08
Double bottom. Technically things are pointing to 150p in short order. Buy
seball
26/4/2024
15:27
double bottom?
tsmith2
26/4/2024
11:54
Yes I agree once they expire in June things could get very interesting..... BUY
seball
26/4/2024
11:34
I see DARK has just been snaffled by a US company. Our pockets are being rifled. I very much suspect that ONT will go the same way once the LAT shares expire in June.
brucie5
Chat Pages: 132  131  130  129  128  127  126  125  124  123  122  121  Older

Your Recent History

Delayed Upgrade Clock